Inside the University of Oregon’s Portland-based Executive MBA program, the cohort looks different: scientists, teachers, board members, parents. Professionals established in their fields—some ...
Kyverna Therapeutics leads CAR-T therapy for autoimmune diseases, with KYV-101 showing unprecedented efficacy in SPS and MG registrational trials. KYTX's SPS trial achieved 81% clinically meaningful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results